SunTrust Starts Bluebird Bio (BLUE) at Buy
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $1.02 +7.37%
Rating Summary:
13 Buy, 16 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Rating Summary:
13 Buy, 16 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 17
Join SI Premium – FREE
SunTrust Robinson Humphrey initiated coverage on Bluebird Bio (NASDAQ: BLUE) with a Buy rating and a price target of $57.00.
For an analyst ratings summary and ratings history on Bluebird Bio click here. For more ratings news on Bluebird Bio click here.
Shares of Bluebird Bio closed at $38.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Agilon, NBH, Shoals, and Blue and Encourages Investors to Contact the Firm
- ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages bluebird bio Inc. Investors to Inquire About Securities Class Action Investigation – BLUE
- Jones Trading Starts Ellington (EFC) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
